J.H. Johnson

502 citations
11 papers · 442 indexed · h-index 9

J.H. Johnson

11 papers receiving 392 citations

Peers

J.H. Johnson
Comparison fields: 5 of 78
  • Equine 26
  • Cancer Research 61
  • Oncology 99
  • Biotechnology 29
  • Surgery 126
Replace M. Järvinen with:
M. Järvinen Finland
Chieh-Fang Cheng United States
Dorota Ścieglińska Poland
Fred Tsen United States
Sonja M. Walzer Austria
Aisuke Nii Japan
Robert G. Sellers United States
Kimberly M. Anderson United States
Osman Çen United States
André Bouchot France
J.H. Johnson relative to M. Järvinen Finland M. Järvinen's profile →
Citations per field
00.5×8.7×
M. Järvinen · 1×
Citations per year

Countries citing papers authored by J.H. Johnson

Since Specialization
Citations

This map shows the geographic impact of J.H. Johnson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J.H. Johnson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J.H. Johnson more than expected).

Fields of papers citing papers by J.H. Johnson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J.H. Johnson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J.H. Johnson. The network helps show where J.H. Johnson may publish in the future.

Co-authorship network

The 15 scholars most cited alongside J.H. Johnson, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with J.H. Johnson Line = papers co-authored together J.H. Johnson links everyone, so they are left out of the graph.

All Works

11 of 11 papers shown
#Work
1 20232
2 200125
3 19805
4 197916
5 197916
6 1979148
7 197958
8 197951
9 197819
10 197822
11 197780

About J.H. Johnson

J.H. Johnson is a scholar working on Equine, Hematology, Biotechnology, Cancer Research and Agronomy and Crop Science, having authored 11 papers that have together received 442 indexed citations. Recurring topics across this work include Peptidase Inhibition and Analysis (2 papers), Blood Coagulation and Thrombosis Mechanisms (2 papers), Protease and Inhibitor Mechanisms (2 papers), Pancreatic function and diabetes (2 papers), Virus-based gene therapy research (1 paper), Hemostasis and retained surgical items (1 paper), Cancer Mechanisms and Therapy (1 paper) and Neuroendocrine Tumor Research Advances (1 paper). The work is most often cited by research in Equine (26 citations), Cancer Research (61 citations), Oncology (99 citations), Biotechnology (29 citations) and Surgery (126 citations). J.H. Johnson has collaborated with scholars based in United States and India. Frequent co-authors include Corey Largman, James W. Brodrick, Michael C. Geokas, Soldano Ferrone, Stephen J. O’Brien, J.C. Petricciani, P. Noguchi, Michele Pellegrino, Julie B. Milstien and R. E. Wallace. Their work appears in journals such as Journal of Biological Chemistry, American Journal of Physiology-Endocrinology and Metabolism, American Journal of Physiology-Gastrointestinal and Liver Physiology, In Vitro Cellular & Developmental Biology - Plant and Journal of Herbs Spices & Medicinal Plants.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026